These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria. Zoccarato M; Grisold W; Grisold A; Poretto V; Boso F; Giometto B Front Neurol; 2021; 12():706169. PubMed ID: 34659082 [TBL] [Abstract][Full Text] [Related]
37. Retrospective study of paraneoplastic neurological syndromes in a Chinese Han population from Shandong, East China. Miao S; Liao S; Li H; Niu B; Hu H; Qian Y; Guo H; Cao B Int J Neurosci; 2018 Sep; 128(9):821-827. PubMed ID: 29355452 [TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome]. Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041 [No Abstract] [Full Text] [Related]
39. Onconeural antibodies in sera from patients with various types of tumours. Monstad SE; Knudsen A; Salvesen HB; Aarseth JH; Vedeler CA Cancer Immunol Immunother; 2009 Nov; 58(11):1795-800. PubMed ID: 19294382 [TBL] [Abstract][Full Text] [Related]
40. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes. Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]